Liang Ding Selected Research

NADPH-Ferrihemoprotein Reductase (Cytochrome P450 Reductase)

1/2021	Lung injury induced by pyrrolizidine alkaloids depends on metabolism by hepatic cytochrome P450s and blood transport of reactive metabolites.
1/2020	Proximal Tubular Vacuolization and Hypersensitivity to Drug-Induced Nephrotoxicity in Male Mice With Decreased Expression of the NADPH-Cytochrome P450 Reductase.
7/2015	Intestinal epithelium-specific knockout of the cytochrome P450 reductase gene exacerbates dextran sulfate sodium-induced colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liang Ding Research Topics

Disease

28	Neoplasms (Cancer) 01/2022 - 10/2014
20	Squamous Cell Carcinoma of Head and Neck 01/2022 - 02/2014
10	Inflammation (Inflammations) 12/2021 - 08/2013
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 01/2012
5	Infections 08/2019 - 10/2013
4	Infarction (Infarctions) 07/2020 - 04/2009
4	Myocardial Infarction 07/2020 - 04/2009
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2021
3	Hypoxia (Hypoxemia) 12/2021 - 05/2014
3	Knee Osteoarthritis 12/2021 - 01/2021
3	Fibrosis (Cirrhosis) 12/2021 - 09/2009
3	Synovitis 12/2021 - 01/2020
3	Myocardial Ischemia (Ischemic Heart Diseases) 07/2020 - 04/2009
3	Osteoarthritis 04/2020 - 01/2018
3	Lymphatic Metastasis 03/2020 - 04/2015
3	Breast Neoplasms (Breast Cancer) 08/2019 - 01/2018
3	Lung Neoplasms (Lung Cancer) 01/2018 - 01/2017
3	Atherosclerosis 01/2017 - 06/2012
2	Melanoma (Melanoma, Malignant) 09/2022 - 01/2022
2	COVID-19 01/2022 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2018
2	Colitis 12/2021 - 07/2015
2	Reperfusion Injury 07/2020 - 10/2017
2	Cardiomyopathies (Cardiomyopathy) 07/2020 - 12/2016
2	Heart Failure 05/2020 - 01/2017
2	Leukoplakia 03/2020 - 04/2015
2	Hypersensitivity (Allergy) 01/2020 - 07/2015
2	Margins of Excision 10/2019 - 01/2019
2	Carcinogenesis 09/2019 - 11/2017
2	Necrosis 08/2019 - 11/2013
2	Brain Neoplasms (Brain Tumor) 01/2019 - 01/2019
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019 - 08/2015
2	Triple Negative Breast Neoplasms 05/2018 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 11/2017
2	Sepsis (Septicemia) 12/2017 - 01/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2017 - 04/2017
2	Hypertrophy 01/2016 - 08/2013
2	Bites and Stings (Sting) 12/2015 - 05/2015
2	Wounds and Injuries (Trauma) 11/2013 - 09/2013
1	Hypertension (High Blood Pressure) 04/2022
1	Prehypertension 04/2022
1	Cytokine Release Syndrome 03/2022

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2009
9	Biomarkers (Surrogate Marker)IBA 09/2022 - 02/2014
6	Messenger RNA (mRNA)IBA 09/2022 - 08/2019
6	Long Noncoding RNAIBA 01/2022 - 01/2017
6	CytokinesIBA 12/2021 - 07/2015
6	RNA (Ribonucleic Acid)IBA 06/2021 - 12/2015
5	Pharmaceutical PreparationsIBA 07/2020 - 12/2014
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2017
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021 - 04/2009
4	2-mercaptopurineIBA 01/2021 - 01/2012
3	Amino Acids FDA Link 12/2021 - 10/2019
3	Lysine (L-Lysine)FDA Link 12/2021 - 11/2017
3	Therapeutic UsesIBA 12/2021 - 01/2017
3	NADPH-Ferrihemoprotein Reductase (Cytochrome P450 Reductase)IBA 01/2021 - 07/2015
3	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2017
2	Tumor Biomarkers (Tumor Markers)IBA 09/2022 - 01/2017
2	Small Interfering RNA (siRNA)IBA 03/2022 - 01/2019
2	EnzymesIBA 12/2021 - 10/2019
2	Dextran SulfateIBA 12/2021 - 07/2015
2	InflammasomesIBA 12/2021 - 01/2020
2	IronIBA 10/2021 - 01/2017
2	Interleukin-18 (Interleukin 18)IBA 01/2021 - 03/2020
2	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 01/2021 - 10/2019
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2021 - 07/2015
2	Interleukin-17 (Interleukin 17)IBA 04/2020 - 04/2015
2	FlavonoidsIBA 04/2020 - 01/2020
2	Histones (Histone)IBA 02/2020 - 01/2019
2	Carrier Proteins (Binding Protein)IBA 11/2019 - 02/2013
2	Mesalamine (Mesalazine)FDA LinkGeneric 07/2019 - 08/2012
2	Interleukin-6 (Interleukin 6)IBA 06/2019 - 12/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 01/2017
2	CalciumIBA 01/2018 - 01/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2017 - 11/2011
2	Glucose (Dextrose)FDA LinkGeneric 11/2017 - 06/2015
2	Phosphotransferases (Kinase)IBA 11/2017 - 01/2017
2	wogoninIBA 11/2017 - 04/2017
2	Lipoproteins (Lipoprotein)IBA 01/2017 - 08/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 11/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2016 - 01/2012
2	InterferonsIBA 12/2015 - 05/2015
2	DNA (Deoxyribonucleic Acid)IBA 12/2015 - 05/2015
2	Azathioprine (Imuran)FDA LinkGeneric 10/2015 - 08/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2015 - 07/2015
2	InterleukinsIBA 07/2015 - 04/2015
2	CollagenIBA 02/2013 - 04/2009
2	integrin-linked kinaseIBA 01/2012 - 09/2009
1	ArsenicIBA 04/2022
1	MetalsIBA 04/2022
1	MolybdenumIBA 04/2022
1	Chemokine ReceptorsIBA 03/2022

Therapy/Procedure

7	Therapeutics 09/2022 - 01/2012
3	Ligation 03/2018 - 09/2009
3	Punctures 03/2018 - 01/2010
2	Immunotherapy 01/2022 - 11/2015
2	Cardiopulmonary Resuscitation (CPR) 01/2021 - 07/2015
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 01/2020
2	Moxibustion 10/2017 - 12/2016
1	Precision Medicine 09/2022